http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2016 Financial Results
-
Opexa to Attend the Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact
-
Opexa Therapeutics Reports 2015 Year End Financial Results and Provides Corporate Update
-
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2015 Financial Results
-
Opexa Therapeutics (OPXA) Announces Restructuring Initiative
-
Opexa Launches Restructuring Initiative to Focus Use of Resources Ahead of Key Phase 2 Data Expected in Early Q4 2016
-
Opexa Therapeutics to Present at the 18th Annual BIO CEO and Investor Conference
-
Opexa Therapeutics Chosen as One of the Top Autoimmune Therapy Projects to Watch
-
Opexa Therapeutics Announces Supportive Preclinical Study Results for its Neuromyelitis Optica (NMO) Program
-
Opexa Therapeutics Reports Third Quarter 2015 Financial Results and Provides Corporate Update
-
Opexa Therapeutics Announces News Release Schedule for Third Quarter 2015 Financial Results
-
Opexa Therapeutics to Host Analyst and Investor Event on November 10 in New York
-
Opexa Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
-
Opexa Therapeutics to Present at BIO Investor Forum
-
Opexa Announces Granting of New T-cell Patents Covering Tcelna®; Patent Estate Increases to 160 Issued Patents
-
Opexa Announces Reverse Stock Split
-
Opexa Secures Private Funding for its NMO Orphan Development Program, Including Planned Phase I/II Clinical Study
-
Opexa Therapeutics to Present at September Conferences
-
Opexa Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update
-
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2015 Financial Results